Updated Monday, 2/24.
While the calendar looks quiet for the week ahead, some small deals may join late.
Singapore healthcare practice Basel Medical (BMGL) is tentatively scheduled to raise $10 million at an $83 million market cap. Through its two medical clinics in Singapore, Basel provides a range of general and subspecialized orthopedic, trauma and sports medicine services. The company offers both clinical services as well as various procedures and minor surgical services on site.
| U.S. IPO Calendar | |||
|---|---|---|---|
| Issuer Business | Deal Size Market Cap | Price Range Shares Filed | Top Bookrunners |
| Basel Medical (BMGL) | $10M $83M | $4 - $5 2,205,000 | Cathay Securities |
| Operates two medical clinics in Singapore. | |||
In the meantime, several sizable deals could launch in the coming week. Names on file eligible to launch include wearable cardiac device maker Kestra Medical Technologies (KMTS), eye disease biotech Aurion Biotech (AURN), industrial power system operator One Power (ONE), and autoimmune disease biotech Odyssey Therapeutics (ODTX).
Street research is expected for five companies in the week ahead, and three lock-up periods will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 2/20/2025, the Renaissance IPO Index was up 4.3% year-to-date, while the S&P 500 was up 4.2%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Kenvue (KVUE) and Arm Holdings (ARM). The Renaissance International IPO Index was up 9.0% year-to-date, while the ACWX was up 7.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Galderma and Porsche.
